PROGENITY, INC. Indenture Agreements

6 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amended and Restated Indenture for 11.00% / 13.00% Convertible Senior Secured Notes due 2028 among Biora Therapeutics, Inc., Guarantors, and GLAS Trust Company LLC
Indenture Agreements
PROGENITY, INC.
Biotechnology
NY
2024
Second Supplemental Indenture between Biora Therapeutics, Inc. and The Bank of New York Mellon Trust Company, N.A. (March 12, 2024)
Indenture Agreements
PROGENITY, INC.
Biotechnology
NY
2024
First Supplemental Indenture to 7.25% Convertible Senior Notes Due 2025 – Biora Therapeutics, Inc. and The Bank of New York Mellon Trust Company, N.A.
Indenture Agreements
PROGENITY, INC.
Biotechnology
NY
2024
Supplemental Indenture to 11.00% / 13.00% Convertible Senior Notes Due 2028 between Biora Therapeutics, Inc. and GLAS Trust Company LLC
Indenture Agreements
PROGENITY, INC.
Biotechnology
NY
2024
Indenture for 11.00% / 13.00% Convertible Senior Secured Notes due 2028 – Biora Therapeutics, Inc., Guarantors, and GLAS Trust Company LLC
Indenture Agreements
PROGENITY, INC.
Biotechnology
NY
2023
Indenture for 7.25% Convertible Senior Notes due 2025 between Progenity, Inc. and The Bank of New York Mellon Trust Company, N.A.
Indenture Agreements
PROGENITY, INC.
Biotechnology
NY
2020